http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9111102-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1323
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0642
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02
filingDate 1991-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e0e21d77c3d9c410e472be8f405495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b32bcf4b55aedeb30cf33861341227a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9c17dc5d7d4125a814b2b8230d96c70
publicationDate 1991-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9111102-A1
titleOfInvention Method for maintaining human neutrophils
abstract Methods for optimizing the viability of human peripheral blood neutrophils in culture and methods for priming neutrophils to exhibit augmented FMLP-stimulated superoxide production without spontaneous superoxide generation are described. Fibroblast-conditioned media and methods for producing same are described as well. Also described is a method for assaying the ability of a compound to enhance the viability of human neutrophils.
priorityDate 1990-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830

Total number of triples: 21.